KYNB — Kyntra Bio, Inc.

KYNBKyntra Bio, Inc.

NAS · US · Healthcare · Biotechnology · kyntrabio.com

7.016USD+0.37%Mkt Cap: 28.40M USDP/E: —Last update: 2026-05-26

Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting C…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap28.40M USD

Enterprise Value-5.39M USD

Revenue (TTM)7.44M USD

Gross Profit5.88M USD

Net Income (TTM)183.45M USD

Revenue/Share1.839 USD

Last Price7.016 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees34

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.71

PEG—

EV/EBITDA0.12

EV/Revenue-0.72

P/S3.78

P/B-0.64

EPS (TTM)-13.99

EPS (Forward)-9.73

52W Range

4.85028% of range12.60

52W High12.60 USD

52W Low4.850 USD

Profitability

Gross Margin91.37%

Oper. Margin-369.07%

EBITDA Margin0.00%

Profit Margin2848.63%

ROE-610.73%

ROA153.40%

Growth

Revenue Growth36.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.77M USD

CapEx (TTM)38.00K USD

FCF Margin—

FCF Yield—

Net Debt-67.99M USD

Net Debt/EBITDA1.55

Balance Sheet

Debt/Equity—

Current Ratio3.60

Quick Ratio3.28

Book Value/Sh-10.8240 USD

Cash/Share21.56 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateJun 17, 2025

Analyst Consensus

Rating2.0 (Buy)

Target (Mean)43.00 USD

Target Range43.00 USD – 43.00 USD

# Analysts1

Ownership

Shares Out.4.05M

Float3.56M

Insiders2.03%

Institutions25.55%

Short Interest

Short Ratio8.4d

Short % Float2.86%

Short % Out.2.80%

Shares Short113.38K

Short (prev mo.)113.88K

Technical

SMA 507.033 (-0.2%)

SMA 2008.930 (-21.4%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)7.94K

Avg Vol (10d)9.26K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—